Others titles
- DEA Exemption List
- SPL Validation Files For DEA Schedule
Keywords
- Structured Products Label
- SPL
- Drug Dictionary
- Pharmaceutical Dictionary
- Drug Names
- Method Validation
- Drug Label
- Drug Enforcement Administration
DEA Exempted Substance Validation Procedure
This dataset is a Structured Product Labeling (SPL) Terminology File for SPL validation procedures and contains information on performing SPL validation regarding DEA (Drug Enforcement Administration) Exempted Substance List.
Get The Data
- ResearchNon-Commercial, Share-Alike, Attribution Free Forever
- CommercialCommercial Use, Remix & Adapt, White Label Log in to download
Description
Validation procedures can be used by humans as check-lists to verify if their submission is correct. These are written specific and operational so that they may be checked by systems processing SPL documents.
The Validation Procedures for DEA Schedule are as follows:
– If the product item code (NDC) is on the DEA Exempt Products List, then there is no DEA schedule.
– If there is a DEA schedule, then the code system is 2.16.840.1.113883.3.26.1.1
– Display name matches the code
– The policy element has a class code of ‘DEADrugSchedule’.
– If the product item code (NDC) is not on the DEA Exempt Products List, then the DEA Schedule matches the one in the Controlled Substance Table where all supplied constraints match.
About this Dataset
Data Info
Date Created | 2016-12-01 |
---|---|
Last Modified | 2022-04-11 |
Version | 2022-04-11 |
Update Frequency |
Irregular |
Temporal Coverage |
N/A |
Spatial Coverage |
United States |
Source | John Snow Labs; US Food & Drug Administration (FDA); |
Source License URL | |
Source License Requirements |
N/A |
Source Citation |
N/A |
Keywords | Structured Products Label, SPL, Drug Dictionary, Pharmaceutical Dictionary, Drug Names, Method Validation, Drug Label, Drug Enforcement Administration |
Other Titles | DEA Exemption List, SPL Validation Files For DEA Schedule |
Data Fields
Name | Description | Type | Constraints |
---|---|---|---|
Type_of_Drug | RX (prescription) or AB (bioequivalent) drug | string | - |
Company_Name | Pharmaceutical company | string | - |
Brand_Name | Commercial name of drug | string | - |
NDC_Code | NDC (National Drug Code) product item code | string | - |
Dosage_Form | Form of product presentation | string | - |
Controlled_Substance_Name | Name of Controlled substance contained in the product | string | - |
Controlled_Substance_Quantity | Quantity of controlled substance in mg or mg/ml | number | level : Ratio |
Other_Substance_Name | Name of ither substance/ingredient | string | - |
Other_Substance_Quantity | Amount of other substance/ingredient | string | - |
Data Preview
Type of Drug | Company Name | Brand Name | NDC Code | Dosage Form | Controlled Substance Name | Controlled Substance Quantity | Other Substance Name | Other Substance Quantity |
RX | Actavis Pharma, Inc. | Butalbital, Acetaminophen and Caffeine Capsules USP 50/300/40 | 0591-2640 | CA | Butalbital | 50.0 | ||
RX | Actavis Pharma, Inc. | Butalbital, Acetaminophen and Caffeine Tablets USP 50/325/40 | 0591-3369 | TB | Butalbital | 50.0 | ||
RX | Actavis Pharma, Inc. | Fioricet (Butalbital, Acetaminophen and Caffeine USP 50/300/40) | 52544-080 | CA | Butalbital | 50.0 | ||
RX | Alpha Scriptics Inc | Butacet Capsules | 53121-0133 | CA | Butalbital | 50.0 | ||
RX | Alphagen Laboratories, Inc. | Butalbital and Acetaminophen Capsules 50mg/ 650mg | 00603-2542 | CA | Butalbital | 50.0 | ||
RX | Alphagen Laboratories, Inc. | Donnaphen Tablets | 59743-0027 | TB | Phenobarbital | 16.2 | ||
RX | Alphagen Laboratories, Inc. | Geone Capsules | 59743-0004 | CA | Butalbital | 50.0 | ||
RX | Altana, Inc. | Axocet (Butalbital and Acetaminophen) | 0281-0389 | TB | Butalbital | 50.0 | ||
RX | Althon Pharmaceuticals, Inc. | Butalbital, Acetaminophen and Caffeine Tablets USP | 66813-074 | TB | Butalbital | 50.0 | ||
RX | American Pharmaceuticals, Inc. | AMERICET Tablets | 58605-0501 | TB | Butalbital | 50.0 |